Clinical Trial Update: Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

A Phase 1 trial of boron phenylalanine with or without mannitol for glioblastoma multiforme has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Boron Phenylalanine (boronophenylalanine)
• Mannitol (mannitol)

Snippet

Sponsor: Cancer Research UK | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: TERMINATED